Contact Home
News area
Press Release area
Studies area
Aspirin in the News area
History
Who We Are
Consumer Information
Professional Info
Contents

Disclaimer

Copyright ©
1999-2008
  Aspirin Foundation
of America




News

Press Release

For Immediate Release

Aspirin Foundation Responds To Meta-Analysis of the Effect of Aspirin on Asthma

February 20, 2004

Aspirin Foundation of America statement in response to the meta-analysis of the effect of aspirin on asthmatics, published in the February 21 issue of the British Medical Journal:

It is important to note that aspirin-induced asthma is triggered in only a small percentage of asthmatics. The association between asthma and aspirin is well-known, and aspirin labeling indicates that asthmatics should consult with their physicians before taking the medication.

In a published media report, Dr. Russell B. Leftwich, assistant clinical professor of medicine at Vanderbilt University and spokesman for the American Academy of Allergy, Asthma and Immunology, says he believes the analysis "overestimate[s] the frequency of aspirin sensitivity." Dr. Rand A. Malone, another Academy spokesman, also took issue with the analysis, saying, "The episode [of aspirin-induced asthma] resolves without therapy in the vast majority of patients."

For those who do not suffer from asthma, aspirin is generally a safe and effective pain reliever. The vast majority who take aspirin have no adverse reaction.

###

Contact:
Caroline Perrin
807 National Press Building, Washington, DC 20036
Phone: 800-432-3247 Fax: 202/737-8406
info@aspirin.org


Home | News | Consumer Section | Professional Section | Table of Contents | Contact us